Bullish option flow detected in Apellis Pharmaceuticals with 3,367 calls trading, 1.7x expected, and implied vol increasing almost 4 points to 134.12%. Aug-23 40 calls and Aug-23 30 calls are the most active options, with total volume in those strikes near 1,500 contracts. The Put/Call Ratio is 0.26. Earnings are expected on November 6th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on APLS:
- Apellis Pharmaceuticals call volume above normal and directionally bullish
- Stifel believes GA market is large enough for Apellis’ Syfovre
- Astellas Pharma announces FDA approval of Izervay for GA
- Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Apellis downgraded to Neutral from Overweight at JPMorgan
Questions or Comments about the article? Write to editor@tipranks.com